|
Volumn 6, Issue 6, 2010, Pages 1031-1042
|
DNA end-processing enzyme polynucleotide kinase as a potential target in the treatment of cancer.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DNA;
DNA TOPOISOMERASE;
ENZYME INHIBITOR;
PHOSPHOTRANSFERASE;
PNKP PROTEIN, HUMAN;
POLYDEOXYRIBONUCLEOTIDE SYNTHASE;
POLYNUCLEOTIDE 5' HYDROXYL KINASE;
TUMOR PROTEIN;
ARTICLE;
DNA DAMAGE;
DNA REPAIR;
DOUBLE STRANDED DNA BREAK;
DRUG ANTAGONISM;
DRUG DELIVERY SYSTEM;
DRUG EFFECT;
FORECASTING;
GENETICS;
HUMAN;
NEOPLASM;
PHYSIOLOGY;
PROTEIN TERTIARY STRUCTURE;
RADIATION EXPOSURE;
SINGLE STRANDED DNA BREAK;
ANTINEOPLASTIC AGENTS;
DNA BREAKS, DOUBLE-STRANDED;
DNA BREAKS, SINGLE-STRANDED;
DNA DAMAGE;
DNA REPAIR;
DNA REPAIR ENZYMES;
DNA TOPOISOMERASES, TYPE I, EUKARYOTIC;
DNA, NEOPLASM;
DRUG DELIVERY SYSTEMS;
ENZYME INHIBITORS;
FORECASTING;
HUMANS;
NEOPLASM PROTEINS;
NEOPLASMS;
PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR);
POLYNUCLEOTIDE 5'-HYDROXYL-KINASE;
PROTEIN STRUCTURE, TERTIARY;
MLCS;
MLOWN;
|
EID: 77957253214
PISSN: None
EISSN: 17448301
Source Type: Journal
DOI: 10.2217/fon.10.40 Document Type: Article |
Times cited : (46)
|
References (0)
|